ABVC BioPharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -145.2% | -145.2% | -93.7% |
| FY2022 | -530.0% | -530.0% | -171.4% |
| FY2023 | -501.1% | -501.1% | -100.0% |
| FY2024 | -399.9% | -399.9% | -65.0% |
| FY2025 | -71.2% | -71.2% | -37.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -145.2% | -145.2% | -93.7% |
| FY2022 | -530.0% | -530.0% | -171.4% |
| FY2023 | -501.1% | -501.1% | -100.0% |
| FY2024 | -399.9% | -399.9% | -65.0% |
| FY2025 | -71.2% | -71.2% | -37.5% |